Toray will provide guidance for the medical institutes and medical/co-medical personnel in close consultation with relevant government officials in using its LIVMOA®5000(
https://www.livmoa.toray/en/index.html) protective clothing, along with promoting their awareness and preparedness for healthcare-associate risks. Toray will also invite key Guinean government officials and concerned public health authorities to Japan aiming to help them upskill and acquire knowledge from Japanese experts in collaboration with specialist institutions in Japan. Toray will contribute for Guinea, as a pilot project given the opportunity by JICA, to assess how Japanese technology could be introduced and mobilized effectively and strategically to promote further visibility as Japan’s qualified product in its global market for health development, addressing its superior quality and performance of LIVMOA®.
LIVMOA® personal protective clothing enables wearers to perform at their best by safeguarding them from body fluids, blood, and their droplet while remaining moisture permeable to optimize comfort hot and humid conditions. Easy removal reduces the risks of secondary infections from on-clothing contaminations.
One priority of Project AP-G 2019, Toray’s medium-term management program, is to expand its capabilities in the life innovation field to enhance its business in clinical and medical environments. The risks of potential outbreaks in Africa of hemorrhagic fevers like Ebola remains critical that require advanced infection control. LIVMOA® personal protective clothing can help various public health efforts including the works conducted in developing countries and bolster their infectious disease prevention programs and deliver better healthcare outcomes.